Scarica l'app Stockscreener
9.42
0.11%
0.010
Dopo l'orario di chiusura:
9.55
0.13
+1.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALVR Giù?
Forum
Previsione
Allovir Inc Borsa (ALVR) Ultime notizie
Allovir director Vikas Sinha sells $1,225 in stock - MSN
Allovir's chief accounting officer sells $342 in common stock - MSN
Allovir's general counsel sells $494 in stock - MSN
Allovir's general counsel sells $494 in stock By Investing.com - Investing.com South Africa
Allovir's chief accounting officer sells $342 in common stock By Investing.com - Investing.com South Africa
Allovir director Vikas Sinha sells $1,225 in stock By Investing.com - Investing.com Australia
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline - GuruFocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCYTH, ALVR, WMPN, OMC - Morningstar
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Inve - GuruFocus.com
AlloVir (NASDAQ:ALVR) Trading 8.2% HigherHere's What Happened - MarketBeat
The Law Offices of Vincent Wong Remind AlloVir Investors of a Lead Plaintiff Deadline of March 19, 2024 - Marketscreener.com
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - Marketscreener.com
AlloVir (NASDAQ:ALVR) Hits New 1-Year LowWhat's Next? - MarketBeat
SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options - Marketscreener.com
ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc.ALVR - Marketscreener.com
Shareholder Alert: Ademi LLP Investigates Whether AlloVir, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Marketscreener.com
AlloVir, Inc. Enter into Termination of Sublease Agreement with AMAG Pharmaceuticals, Inc - Marketscreener.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir - Marketscreener.com
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. LawsuitALVR - Marketscreener.com
Jane Street Group LLC Sells 89,680 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World
AlloVir executes reverse stock split By Investing.com - Investing.com Australia
AlloVir executes reverse stock split - Investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Allovir stock plunges to 52-week low, touches $0.4 By Investing.com - Investing.com Australia
Allovir’s Vikas Sinha sells shares worth $430 By Investing.com - Investing.com Nigeria
Allovir's Vikas Sinha sells shares worth $430 By Investing.com - Investing.com Australia
Allovir’s general counsel Edward Miller sells $180 in stock By Investing.com - Investing.com Nigeria
Allovir’s chief accounting officer sells $146 in common stock By Investing.com - Investing.com Nigeria
Allovir's chief accounting officer sells $146 in common stock By Investing.com - Investing.com Australia
Allovir's general counsel Edward Miller sells $180 in stock By Investing.com - Investing.com Australia
Allovir's chief accounting officer sells $146 in common stock - Investing.com India
Allovir's general counsel Edward Miller sells $180 in stock - Investing.com India
Allovir stock plunges to 52-week low, touches $0.4 - Investing.com India
Geode Capital Management LLC Lowers Stock Position in AlloVir, Inc. (NASDAQ:ALVR) - Defense World
Reviewing AlloVir (NASDAQ:ALVR) and Turnstone Biologics (NASDAQ:TSBX) - Defense World
AlloVir, Inc. Reports Positive Voting Outcome for Proposed Reverse Stock Split - Defense World
AlloVir announces reverse stock split effective January 16 By Investing.com - Investing.com Australia
AlloVir announces reverse stock split effective January 16 - Investing.com India
AlloVir shareholders approve reverse stock split - Investing.com
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):